Evidence map›Paper›PMID 30607020›Full record

ArticleLeukemia2019

Dichotomous Toll-like receptor responses in chronic lymphocytic leukemia patients under ibrutinib treatment.

Maria Gounari, Stavroula Ntoufa, Marina Gerousi, Maria Giovanna Vilia, Theodoros Moysiadis, Konstantia Kotta, Nikos Papakonstantinou, Lydia Scarfò, Andreas Agathangelidis, Eleonora Fonte and 9 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Stereotyped B-Cell Receptor Immunoglobulins in B-Cell Lymphomas.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  4. Article
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Maria Gounari *Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
Stavroula Ntoufa *Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
Marina GerousiInstitute of Applied Biosciences, CERTH, Thessaloniki, Greece.
Maria Giovanna ViliaDivision of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.
Theodoros MoysiadisInstitute of Applied Biosciences, CERTH, Thessaloniki, Greece.
Konstantia KottaInstitute of Applied Biosciences, CERTH, Thessaloniki, Greece.
Nikos PapakonstantinouInstitute of Applied Biosciences, CERTH, Thessaloniki, Greece.
Lydia ScarfòDivision of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.
Andreas AgathangelidisInstitute of Applied Biosciences, CERTH, Thessaloniki, Greece.
Eleonora FonteDivision of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.
Pamela RanghettiDivision of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.
Athanasia NenouInstitute of Applied Biosciences, CERTH, Thessaloniki, Greece.
Aliki XochelliInstitute of Applied Biosciences, CERTH, Thessaloniki, Greece.
Marta CosciaDivisione di Ematologia dell'Università di Torino, Azienda Ospedaliero Universitaria S. Giovanni Battista di Torino, Torino, Italy.
Alessandra TedeschiDepartment of Oncology/Haematology, Niguarda Cancer Center, Niguarda Ca Granda Hospital, Milan, Italy.
Niki StavroyianniHematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
Marta Muzio *Division of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.
Kostas Stamatopoulos *Institute of Applied Biosciences, CERTH, Thessaloniki, Greece. kostas.stamatopoulos@gmail.com.
Paolo Ghia *Division of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.ORCID http://orcid.org/0000-0003-3750-7342

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenineGene Expression Regulation, NeoplasticHumansLeukemia, Lymphocytic, Chronic, B-CellPiperidinesPrognosisPyrazolesPyrimidinesToll-Like ReceptorsAdenineibrutinibPiperidinesPyrazolesPyrimidinesToll-Like Receptors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.